+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Differential release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human granulosa-lutein cells and ovarian leukocytes



Differential release of matrix metalloproteinases and tissue inhibitors of metalloproteinases by human granulosa-lutein cells and ovarian leukocytes



Endocrinology 151(3): 1290-1298



Tissue reorganization during ovulation and corpus luteum formation involves a coordinated action of matrix metalloproteinases (MMPs) and tissue MMP inhibitors (TIMPs). In this study we investigated the cellular source of ovarian MMPs and TIMPs. Cells isolated from the preovulatory human follicle were cultured after immunobead depletion of CD45-expressing cells, which allowed differential assessment of leukocyte and granulosa-lutein cell fractions. Secretion of MMP-9 by follicular fluid-derived cells was associated with the presence of leukocytes. Granulosa-lutein cells synthesized low levels of MMP-9 but failed to secrete this enzyme that presumably accumulated in the cytoplasm, indicated by an increased MMP-9 expression of luteinized cells in sectioned midluteal phase corpora lutea. Synthesis and secretion of TIMP by follicular fluid-derived cells was associated with granulosa-lutein cells. TIMPs derived by granulosa-lutein cells failed to inhibit MMP-related pericellular proteolysis. The findings support a two-cell model of periovulatory MMP/TIMP release, in which leukocytes secrete MMPs and granulosa-lutein cells release TIMP, suggesting that there exists an intriguing interaction among cells that intertwingle during ovulation and corpus luteum formation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052615158

Download citation: RISBibTeXText

PMID: 20051489

DOI: 10.1210/en.2009-0605


Related references

Differential release of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in patients following alcohol induced myocardial infarction. Circulation 104(17 Suppl.): II 305, October 23, 2001

Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo. Journal of Clinical Endocrinology and Metabolism 90(10): 5848-5857, 2005

Differential expression of tissue inhibitors of matrix metalloproteinases and matrix metalloproteinases in cells of B- and T-cell origin. Laboratory Investigation 68(1): 100A, 1993

Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Experimental Gerontology 31(1-2): 207-223, 1996

Langerhans cells express matrix metalloproteinases 9 and 2 and tissue inhibitors of metalloproteinases 1 and 2 in healthy human gingival tissue and in periodontitis. Oral Microbiology and Immunology 21(3): 197-200, 2006

Is collagen breakdown during periodontitis linked to inflammatory cells and expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gingival tissue?. Journal of Periodontology 72(10): 1398-1406, 2001

Matrix metalloproteinases and tissue inhibitors of metalloproteinases are expressed in human pterygia and cultured pterygium epithelial cells. IOVS 40(4): S771, March 15, 1999

Differential regulation of the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases by cytokines and growth factors in bovine endometrial stromal cells and trophoblast cell line BT-1 in vitro. Biology of Reproduction 68(4): 1276-1281, 2003

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells. Immunology 105(1): 73-82, 2002

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in totipotent human embryonic neural stem cells A possible model for glioma invasion. Proceedings of the American Association for Cancer Research Annual Meeting 39: 292, 1998

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in cultured human embryonic CNS stem cells which give rise to neurons and glia. Society for Neuroscience Abstracts 23(1-2): 594, 1997

Matrix metalloproteinases and tissue inhibitors of metalloproteinases in ovarian function. Reviews of Reproduction 3(1): 23-30, 1998

Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gliomatosis peritonei derived from ovarian immature teratoma. Acta Histochemica et Cytochemica 31(1): 65-69, 1998

Differential regulations of matrix metalloproteinases and tissue inhibitors of metalloproteinases in dermal fibroblasts by dibutyryl cyclic AMP. Journal of Dermatological Science 15(2): 95-100, 1997

Differential regulations of matrix metalloproteinases and tissue inhibitors of metalloproteinases in dermal fibroblasts by dibutyril cyclic Amp. Journal of Dermatological Science 15(2): 95-100, 1997